Skip to content

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04986553
Enrollment
0
Registered
2021-08-03
Start date
2021-05-20
Completion date
2023-07-30
Last updated
2024-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clavicle Fracture

Brief summary

The objective of the registry is to evaluate the continued safety and performance of Arthrex Clavicle Plates used to treat clavicle fractures.

Detailed description

To assess safety, device-related adverse events will be reported and evaluated over the course of the study. To evaluate the performance imaging of the target area will be evaluated at three months postoperative. Additionally, patient-reported outcomes will be evaluated at three months postoperative, 6 months postoperative, and one year postoperative using the Visual Analogue Scale (VAS), Veterans Rand 12-Item Health Survey (VR-12), and American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES).

Interventions

DEVICEArthrex Clavicle Plates

Arthrex Clavicle Plate for treatment of clavicle fractures

Sponsors

Arthrex, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. The subject requires surgery using the Arthrex Clavicle Plate for clavicle fracture. 2. The subject is 18 years of age or over. 3. The subject is not considered a vulnerable subject (i.e., child, pregnant, nursing, prisoner, or ward of the state). 4. Subject signed informed consent and is willing and able to comply with all study requirements

Exclusion criteria

1. Insufficient quantity or quality of bone. 2. Blood supply limitations and previous infections, which may retard healing. 3. Foreign-body sensitivity. 4. Any active infection or blood supply limitations. 5. Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period. 6. Subjects that are skeletally immature.

Design outcomes

Primary

MeasureTime frameDescription
To assess a change in American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)Preoperatively, 3 months, 6 months and 12 months postoperativelyASES is a 100-point scale that consists of two dimensions: pain and activities of daily living. There is one pain scale worth 50 points and ten activities of daily living worth 50 points.
To assess a change in Visual Analogue Scale (VAS) surveyPreoperatively, 3 months, 6 months and 12 months postoperativelyPatient reported pain scale 0-10 point scale (0 min,10 max)
To assess a change in Veterans Rand 12-Item Health Survey (VR-12)Preoperatively, 3 months, 6 months and 12 months postoperativelyPatient reported changes in general health and mental survey. Average score is 50 (negative answers bring scores down, positive answers bring scores up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026